We are live on ! Find out more
CCS

Crosspoint Capital Strategies Portfolio holdings

AUM $50.4M
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+11.45%
1 Year Est. Return
-15.37%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
-$79.4M
Cap. Flow
-$91M
Cap. Flow %
-43.93%
Top 10 Hldgs %
21.97%
Holding
890
New
197
Increased
94
Reduced
202
Closed
375

Top Buys

Rank Stock Value
1
DMLP icon
Dorchester Minerals
DMLP
+$5.04M
2
AMBA icon
Ambarella
AMBA
+$3.51M
3
TCRT icon
Alaunos Therapeutics
TCRT
+$3.39M
4
CELG
Celgene Corp
CELG
+$3.33M
5
SONC
Sonic Corp
SONC
+$3.31M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$7.89M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$6.46M
3
AAPL icon
Apple
AAPL
+$5.32M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.25M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 17.98%
2 Technology 16.3%
3 Consumer Discretionary 16.11%
4 Consumer Staples 11.7%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HNP
401
DELISTED
Huaneng Power Intl, Inc.
HNP
$8K ﹤0.01%
+161
New +$8.16K
BHI
402
DELISTED
Baker Hughes
BHI
$8K ﹤0.01%
125
-1,531
-92% -$92.4K
ASPX
403
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$8K ﹤0.01%
+78
New +$5.2K
BLUE
404
DELISTED
bluebird bio
BLUE
$7K ﹤0.01%
+4
New +$5.28K
HSBC icon
405
HSBC
HSBC
$352B
$7K ﹤0.01%
+186
New +$7.25K
IOO icon
406
iShares Global 100 ETF
IOO
$9.36B
$7K ﹤0.01%
+180
New +$6.91K
PAYX icon
407
Paychex
PAYX
$45B
$7K ﹤0.01%
+133
New +$6.46K
SSL icon
408
Sasol
SSL
$7.44B
$7K ﹤0.01%
+212
New +$7.62K
LUMO
409
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$7K ﹤0.01%
+15
New +$5.81K
CEMP
410
DELISTED
Cempra, Inc.
CEMP
$7K ﹤0.01%
+190
New +$5.71K
CBPO
411
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$7K ﹤0.01%
72
+3
+4% +$224
WBK
412
DELISTED
Westpac Banking Corporation
WBK
$7K ﹤0.01%
226
-74
-25% -$2.12K
DEG
413
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
$7K ﹤0.01%
+304
New +$6.46K
ANAC
414
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$7K ﹤0.01%
122
-40
-25% -$1.7K
ALLE icon
415
Allegion
ALLE
$13.6B
$6K ﹤0.01%
+101
New +$5.77K
AMN icon
416
AMN Healthcare
AMN
$1.36B
$6K ﹤0.01%
+239
New +$4.95K
AMX icon
417
America Movil
AMX
$70.4B
$6K ﹤0.01%
297
-601
-67% -$12.9K
BWX icon
418
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.32B
$6K ﹤0.01%
+208
New +$5.61K
COR icon
419
Cencora
COR
$61.3B
$6K ﹤0.01%
50
-600
-92% -$60.4K
CVLG icon
420
Covenant Logistics
CVLG
$902M
$6K ﹤0.01%
336
-124
-27% -$1.88K
FICO icon
421
Fair Isaac
FICO
$25B
$6K ﹤0.01%
+62
New +$4.99K
IGF icon
422
iShares Global Infrastructure ETF
IGF
$10.5B
$6K ﹤0.01%
+150
New +$6.29K
IYM icon
423
iShares US Basic Materials ETF
IYM
$1.05B
$6K ﹤0.01%
+70
New +$5.8K
IYZ icon
424
iShares US Telecommunications ETF
IYZ
$1.29B
$6K ﹤0.01%
185
-110
-37% -$3.31K
MATX icon
425
Matsons
MATX
$6.64B
$6K ﹤0.01%
+132
New +$5.01K
15 16
17
18 19

Similar funds

ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
SJIA
St. James Investment Advisors Port Jefferson, New York $54.6M AUM 0.39% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
DFAM
Deep Field Asset Management Beverly Hills, California $57.7M AUM 29.92% 1-Year Est. Return
AI
Abanco Investors Middletown, Rhode Island $57.9M AUM
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return

Crosspoint Capital Strategies's Q1 2015 Portfolio in Review

As of Q1 2015, Crosspoint Capital Strategies held 890 positions worth $207M, down 28% from $287M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Crosspoint Capital Strategies withdrew a net $91M in Q1 2015, closing 375 positions and reducing 202 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Crosspoint Capital Strategies opened a new position in Dorchester Minerals worth $4.64M.

  • Crosspoint Capital Strategies's largest Q1 2015 buy was Dorchester Minerals: 204,210 shares worth $4.64M.
  • Crosspoint Capital Strategies added most to Ambarella in Q1 2015, an estimated $3.51M increase.
  • Crosspoint Capital Strategies's biggest Q1 2015 reduction was Berkshire Hathaway Class B, cutting an estimated $7.89M.
  • Crosspoint Capital Strategies fully exited Agios Pharmaceuticals in Q1 2015, selling an estimated $4.46M.
  • Crosspoint Capital Strategies's ten largest holdings make up 22% of its $207M portfolio in Q1 2015.
  • Crosspoint Capital Strategies opened 197 new positions and closed 375 in Q1 2015.
  • Crosspoint Capital Strategies's portfolio value fell 28% quarter-over-quarter to $207M.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2015, filed 18 May 2015.